La Miocardiopatía Dilatada (página 3)

52. Gulick TS, Chung MK,
Pieper SJ, Lange LG, Schreiner GF. Interleukin 1 and
tumor necrosis factor inhibit cardiac myocite beta
adrenergic responsiveness. Proc Natl Acad Sci USA
1989; 86: 6753-6757. 

53. Chung MK, Gulick TS,
Rotondo RE, Schreiner GF, Lange LG. Mechanism of
cytokine inhibition of adrenergic agonist stimulation
of cyclic AMP in rat cardiac myocytes. Impairment of
signal transduction. Circ Res 1990;
67:753-763. 

54. Blum A, Miller H: Role
of cytokines in heart failure. Am Heart J 1998;
135:181-186. 

55. Dutra WO, Gollob KJ,
Pinto-Días JC, Gazzinelli G, Correa-Oliveira
R, Coffman RL, Carvalho-Parra JF. Cytokine mRNA
profile of peripheral blood mononuclear cells
isolated from individuals with Trypanosoma cruzi
infection. Scand J Immunol 1997;
45:74-80. 

56. Ward LS, Guariento ME,
Fernandes GA, Maciel RM. Serum cytokines in chronic
Chagas" disease. Rev Soc Bras Med Trop 1999;
32:285-289. 

57. Perez-Fuentes R,
Guegan JF, Barnabe C, Lopez-Colombo A, Salgado-Rosas
H, Torres-Rasgado E, Briones B, Romero-Diaz M,
Ramos-Jimenez J, Sanchez-Guillén M del C.
Severity of chronic Chagas disease is associated with
cytokine/antioxidant imbalance in chronically
infected individuals. Int J Parasitol 2003;
33:293-299. 

58. Ferreira RC, Ianni BM,
Abel LC, Buck P, Mady C, Kalil J, Cunha-Neto E.
Increased plasma levels of tumor necrosis
factor-alpha in asymptomatic/"indeterminate" and
Chagas disease cardiomyopathy patients. Mem Inst
Oswaldo Cruz 2003; 98:407-411. 

59. Talvani A, Rocha MO,
Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM.
Elevated concentrations of CCL2 and tumor necrosis
factor-alpha in chagasic cardiomyopathy. Clin Infect
Dis 2004; 38: 943-950. 

60. Añez N,
González N, Crisante G, Rojas A, Premoli G,
Ramírez JL, Guevara P y Chiurillo MA. Curso
Taller: Pruebas confirmatorias en el
diagnóstico de la enfermedad de Chagas. XVIII
Jornadas "José Witremundo Torrealba". 1999;
San Carlos, Venezuela. 

61. Carrasco HA, Parada H,
Guerrero L, Duque M, Duran D, Molina C. Prognostic
implications of clinical, electrocardiographic and
hemodynamic findings in chronic Chagas" disease. Int
J Cardiol 1994; 43:27-38. 

62. Reis DD, Jones EM,
Tostes Jr S, Lopes ER, Gazzinelli G, Colley DG,
McCurley TL Characterization of inflammatory
infiltrates in chronic chagasic myocardial lesions:
presence of tumor necrosis factor+ cells and
dominance of granzyme A+, CD8+ lymphocytes. Am J Trop
Med Hyg 1993; 48: 637-644. 

63. Souza PE, Rocha MO,
Rocha-Vieira E, Menezes CA, Chaves AC, Gollob KJ,
Dutra WO. Monocytes from patients with indeterminate
and cardiac forms of Chagas" disease display distinct
phenotypic and functional characteristics associated
with morbidity. Infect Immun 2004;
72:5283-5291. 

64. Menezes CA, Rocha MO,
Souza PE, Chaves AC, Gollob KJ, Dutra WO. Phenotypic
and functional characteristics of CD28+ and CD28-
cells from chagasic patients: distinct repertoire and
cytokine expression. Clin Exp Immunol 2004;
137:129-138. 

65. Cunha-Neto E, Rizzo
LV, Albuquerque F, Abel L, Guilherme L, Bocchi E,
Bacal F, Carrara D, Ianni B, Mady C, Kalil J.
Cytokine production profile of heart-infiltrating T
cells in Chagas" disease cardiomyopathy. Braz J Med
Biol Res 1998; 31:133-137. 

66. Sharma R, Al-Nasser
FO, Anker SD. The importance of tumor necrosis factor
and lipoproteins in the pathogenesis of chronic heart
failure. Heart Fail Monit 2001; 2:
42-47. 

67. Derouich-Guergour D,
Brenier-Pinchart MP, Ambroise-Thomas P, Pelloux H.
Tumour necrosis factor alpha receptors: role in the
physiopathology of protozoan parasite infections. Int
J Parasitol 2001; 31: 763-769. 

68. Aggarwal BB, Natarajan
K. Tumor necrosis factor: developments during the
last decade. Eur Cytokyne Netw 1996; 7:
93-124. 

69. Chen G, Goedel DV.
TNF-R1 signaling: a beautiful pathway. Science 2002;
296:1634-1635. 

70. Laucella SA,
Rottenberg ME, De Titto EH. Role of cytokines in
resistance and pathology in Trypanosoma cruzi
infection. Rev Argent Microbiol 1996;
28:99-109. 

71. Muller-Werdan U,
Engelmann H, Werdan K. Cardiodepression by tumor
necrosis factor-alpha. Eur Cytokine Netw 1998;
9:689-691. 

72. Mady C, Cardoso RH,
Barretto AC, da LP, Bellotti G, Pileggi F. Survival
and predictors of survival in patients with
congestive heart failure due to Chagas
cardiomyopathy. Circulation 1994;
90:3098-3102. 

73. Palacios-Pru E,
Carrasco H, Scorza C, Espinoza R. Ultrastructural
characteristics of different stages of human chagasic
myocarditis. Am J Trop Med Hyg 1989; 41:
29-40. 

74. Andrade ZA.
Immunopathology Chagas" disease. Mem. Inst Oswaldo
Cruz 1999; 94: 71-80.

75. Mendall MA, Patel P,
Asante M, Ballam L, Morris J, Strachan DP, Camm AJ,
Northfield TC. Relation of serum cytokine
concentrations to cardiovascular risk factors and
coronary heart disease. Heart 1997 Sep;
78(3):273-277. 

76. Barbosa Jr AA, Andrade
ZA. Identificação do Trypanososoma
cruzi nos tecidos extracardíacos de portadores
de miocardite crônica chagásica. Rev Soc
Bras Med Trop 1984; 17:123-126. 

77. Novoa-Montero,
D. ¿Cardiopatía crónica
endémica rural chagásica, o
crónica común en chagásicos y no
chagásicos? (Conclusiones de veinte
años de investigaciones epidemiológicas
y clínico-cardiológicas en Venezuela).
Rev Soc Ven Microbiol 2002;
22:88-98. 

78. Salones O, Santoya L,
Sibulo C, Suárez S, Terán L, Jara A,
Rodríguez-Bonfante C, Arrieche S. Estudio
electrocardiográfico de individuos
seropositivos y seronegativos para Trypanosoma cruzi
de la comunidad de arenales, municipio Torres, estado
Lara. Acta Cient Venez 2004; 55 (Sup.1):
145. 

79. Cihakova D, Sharma RB,
Fairweather D, Afanasyeva M, Rose NR. Animal models
for autoimmune myocarditis and autoimmune
thyroiditis. Methods Mol Med 2004;
102:175-194. 

80. Feldman AM, Combes A,
Wagner D, Kadakomi T, Kubota T, Li YY, McTiernan C.
The role of tumor necrosis factor in the
pathophysiology of heart failure. J Am Coll Cardiol
2000; 35:537-544. 

81. .KIERSZENBAUM F.
Mechanisms of Pathogenesis in Chagas disease. Acta
Parasitol 2007; 52: 1-12.